{"transactions":[{"id":678531,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":20763,"kind":"person","name":"Graf Susan E","position":1,"cik":"0001577637","reported_name":"Graf Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-21T23:46:53.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":44964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of (i) August 14, 2027, and (ii) immediately prior to the Registrant's next Annual Meeting of Stockholders following the date of grant, subject to the Reporting Person's continuous service through the applicable vesting date, inclusive."}],"balance_after":44964,"derivative":{"exercise_price":6.54,"expiration_date":"2036-08-14","underlying":"Common Stock","underlying_shares":44964},"source":{"system":"sec-edgar","filing":"0001193125-26-361486","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1577637/000119312526361486/ownership.xml","form_type":"4"}},{"id":747506,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":20763,"kind":"person","name":"Graf Susan E","position":1,"cik":"0001577637","reported_name":"Graf Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-05T20:30:04.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":9354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following June 4, 2026, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":9354,"derivative":{"exercise_price":56.09,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":9354},"source":{"system":"sec-edgar","filing":"0001193125-26-259688","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1577637/000119312526259688/ownership.xml","form_type":"4"}},{"id":1111051,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":20763,"kind":"person","name":"Graf Susan E","position":1,"cik":"0001577637","reported_name":"Graf Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-13T20:05:04.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":30508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on June 11, 2026, subject to the Reporting Person's continuous service through the vesting date, inclusive."}],"balance_after":30508,"derivative":{"exercise_price":11.29,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":30508},"source":{"system":"sec-edgar","filing":"0000950170-25-086138","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1577637/000095017025086138/ownership.xml","form_type":"4"}},{"id":1119186,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":20763,"kind":"person","name":"Graf Susan E","position":1,"cik":"0001577637","reported_name":"Graf Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-06T21:01:36.000Z","date":"2025-06-05","kind":"grant","planned":true,"acquired":true,"shares":24165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following June 5, 2025, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":24165,"derivative":{"exercise_price":26.63,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":24165},"source":{"system":"sec-edgar","filing":"0000950170-25-083235","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1577637/000095017025083235/ownership.xml","form_type":"4"}},{"id":1389929,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":20763,"kind":"person","name":"Graf Susan E","position":1,"cik":"0001577637","reported_name":"Graf Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-07T21:09:55.000Z","date":"2024-10-04","kind":"grant","planned":false,"acquired":true,"shares":15600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following October 4, 2024, the date of grant, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":15600,"derivative":{"exercise_price":36.63,"expiration_date":"2034-10-03","underlying":"Common Stock","underlying_shares":15600},"source":{"system":"sec-edgar","filing":"0000950170-24-113314","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1577637/000095017024113314/ownership.xml","form_type":"4"}},{"id":1860080,"issuer":{"id":90094,"kind":"organization","name":"Finch Therapeutics Group, Inc.","symbol":"FNCH"},"owners":[{"id":20763,"kind":"person","name":"Graf Susan E","position":1,"cik":"0001577637","reported_name":"Graf Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-09T20:15:17.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in twelve equal monthly installments beginning on July 8, 2023, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":10000,"derivative":{"exercise_price":0.285,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-23-015177","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1577637/000089924323015177/doc4.xml","form_type":"4"}},{"id":1860079,"issuer":{"id":90094,"kind":"organization","name":"Finch Therapeutics Group, Inc.","symbol":"FNCH"},"owners":[{"id":20763,"kind":"person","name":"Graf Susan E","position":1,"cik":"0001577637","reported_name":"Graf Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T20:15:17.000Z","date":"2023-06-09","kind":"purchase","planned":false,"acquired":true,"shares":5010,"price":0.27,"value":1352.7,"ownership":{"direct":true},"balance_after":5010,"source":{"system":"sec-edgar","filing":"0000899243-23-015177","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1577637/000089924323015177/doc4.xml","form_type":"4"}},{"id":2231102,"issuer":{"id":90094,"kind":"organization","name":"Finch Therapeutics Group, Inc.","symbol":"FNCH"},"owners":[{"id":20763,"kind":"person","name":"Graf Susan E","position":1,"cik":"0001577637","reported_name":"Graf Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-15T21:04:54.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":44843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in twelve equal monthly installments beginning on July 13, 2022, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":44843,"derivative":{"exercise_price":2.79,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":44843},"source":{"system":"sec-edgar","filing":"0000899243-22-022619","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1577637/000089924322022619/doc4.xml","form_type":"4"}},{"id":2738162,"issuer":{"id":90094,"kind":"organization","name":"Finch Therapeutics Group, Inc.","symbol":"FNCH"},"owners":[{"id":20763,"kind":"person","name":"Graf Susan E","position":1,"cik":"0001577637","reported_name":"Graf Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-27T21:12:25.000Z","date":"2021-04-23","kind":"grant","acquired":true,"shares":23419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3rd) of the shares subject to the option vest on April 23, 2022, and the remaining shares subject to the option shall vest in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":23419,"derivative":{"exercise_price":14,"expiration_date":"2031-04-22","underlying":"Common Stock","underlying_shares":23419},"source":{"system":"sec-edgar","filing":"0001209191-21-028601","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1577637/000120919121028601/doc4.xml","form_type":"4"}},{"id":4062083,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":20763,"kind":"person","name":"Graf Susan E","position":1,"cik":"0001577637","reported_name":"Graf Susan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-13T17:05:56.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":106344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 9, 2018 pursuant to the Company's 2013 Stock Incentive Plan with respect to 106,344 shares of Common Stock, with 25% vesting on February 9, 2019 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":106344,"derivative":{"exercise_price":16,"expiration_date":"2028-02-08","underlying":"Common Stock","underlying_shares":106344},"source":{"system":"sec-edgar","filing":"0001209191-18-009635","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1571498/000120919118009635/doc4.xml","form_type":"4"}},{"id":4459149,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":20763,"kind":"person","name":"Graf Susan E","position":1,"cik":"0001577637","reported_name":"Graf Susan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-09T17:55:14.000Z","date":"2017-02-08","kind":"grant","acquired":true,"shares":109866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 8, 2017 pursuant to the Company's 2013 Stock Incentive Plan with respect to 109,866 shares of Common Stock, with 25% vesting on February 8, 2018 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":109866,"derivative":{"exercise_price":12.45,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":109866},"source":{"system":"sec-edgar","filing":"0001209191-17-009197","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1571498/000120919117009197/doc4.xml","form_type":"4"}}]}